SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-199074
Filing Date
2019-07-22
Accepted
2019-07-22 17:08:33
Documents
6
Period of Report
2019-07-19
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.08: Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d754556d8k.htm 8-K 44487
2 EX-2.3 d754556dex23.htm EX-2.3 16707
3 EX-3.1 d754556dex31.htm EX-3.1 8328
4 EX-3.2 d754556dex32.htm EX-3.2 120970
5 EX-10.1 d754556dex101.htm EX-10.1 57923
6 EX-99.1 d754556dex991.htm EX-99.1 10297
  Complete submission text file 0001193125-19-199074.txt   260336
Mailing Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199
Business Address 800 BOYLSTON STREET 24TH FLOOR BOSTON MA 02199 617-874-1821
Flex Pharma, Inc. (Filer) CIK: 0001615219 (see all company filings)

IRS No.: 465087339 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36812 | Film No.: 19966328
SIC: 2834 Pharmaceutical Preparations